Marshall Glesby

Professor with a passion for advancing studies in clinical epidemiology and health services research, Marshall Glesby is a distinguished faculty member at the Graduate School of Medical Sciences, Weill Cornell Medicine. His extensive research portfolio is centered on the intricate metabolic complications associated with HIV-infected patients. This includes exploring lipid elevations, body shape changes known as lipodystrophy, and disorders of glucose metabolism, which are critical areas of concern for improving patient outcomes. In addition to his work on metabolic complications, Professor Glesby is deeply involved in investigating liver disease, particularly focusing on innovative therapeutic approaches for HCV/HIV co-infection. His research aims to uncover novel treatment strategies that can significantly enhance the quality of life for individuals affected by these co-existing conditions. Professor Glesby is also a key contributor to the NIH-sponsored Women's Interagency HIV Study, where he examines various aspects of HIV disease. This study is pivotal in understanding the unique challenges faced by women living with HIV and developing tailored interventions to address their needs. His collaborative efforts extend internationally, as he works with researchers in Brazil on epidemiological studies of HTLV-I and clinical trials of cutaneous leishmaniasis, showcasing his commitment to global health issues. Through his dedication to research and collaboration, Professor Glesby continues to make significant strides in the field of clinical epidemiology, contributing to the advancement of medical science and the betterment of patient care worldwide.